STEERING COMMITTEE NOMINEES FOR THREE VACANCIES MARCH 2018

Similar documents
Clinical Research Professionals

GCP INSPECTORATE GCP INSPECTIONS METRICS REPORT

Why do we need an addendum to ICH E6?

Addendum to ICH E6 (R2)

CQA Consultant of HVCC, Hilversum, the Netherlands. Coaching of auditors on various levels is an on-going activity.

NANCI A. HAYWARD North Springs Drive Dunwoody, Georgia

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Standard Operating Procedure Research Governance

Overview ICH GCP E6(R2) Integrated Addendum

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

September 2-3, 2013 Chengdu, China

ICH Regulators Forum. Dr Peter Arlett EU

Investigator Initiated-Sponsored Research (IISR)

STANDARD OPERATING PROCEDURE SOP 325

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Physician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1

R. Fay, Research Governance & GCP Manager K. Mahiouz, Clinical Trials Facilitator E. Clough, R&D Governance Operations Manager

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Solutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session

Solutions for GCP Compliance Challenges

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

STANDARD OPERATING PROCEDURE

Royal Children s Hospital- Melbourne Information Session

Clinical Study Risk Assessment

Trial Management: Trial Master Files and Investigator Site Files

STANDARD OPERATING PROCEDURE

Corporate. Research Governance Policy. Document Control Summary

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

STANDARD OPERATING PROCEDURE

Standard Operating Procedures

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Work plan for GCP Inspectors Working Group for 2018

Storage and Archiving of Research Documents SOP 6

Regulatory Submissions Trends Survey 2002 Ellen Semple Date received (in revised form): 18th March, 2003

Overview of the Regulatory Framework for the Safety of Nuclear Power Plants in Romania

PMDA EPOCH Toward 2020

Introduction To Medpace & Clinical Research Overview

Keele Clinical Trials Unit

Research & Development Quality Manual

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

2017 Clinical Trials Data Library

QUALITY & REGULATORY APPRENTICESHIP PROGRAM

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Document Title: Investigator Site File. Document Number: 019

Preview EUR PEAN PHARMACO VIGILANCE CONGRESS

IMPROVING YOUR CLINICAL TRIAL & ENHANCING THE PATIENT EXPERIENCE

Training & Resources for Clinical Research Professionals

Regulatory Cooperation Forum

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

This is a full time post offered on a fixed-term basis until 31 August 2019.

ICD-10: Capturing the Complexities of Health Care

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by

Risk Assessment and Monitoring

Margaret Huber, RN, CHRC Compliance Consultant Office of Research Compliance

QUALITY TIPS FOR CLINICAL SITES. Athena Thomas-Visel. Clinical Quality Consultant QUALITY TIPS FOR CLINICAL SITES

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

RECORD RETENTION: Imaging Data Longevity

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Informatics Merseyside Careers in health informatics

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

What next for Life Sciences? Vir Lakshman

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

STANDARD OPERATING PROCEDURE

Position Profile President & CEO, National Home Infusion Association Alexandria, VA

Preparation for an MHRA GCP Inspection including Training on New and Up-dated SOPs

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

STH Researcher. Recording of research information in patient case notes

IMPA 2 CT REPORT 017

Document Title: Study Data SOP (CRFs and Source Data)

NIHR Medicines for Children Research Network Response January 2010

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

1. Introduction, purpose of this Standard Operating Procedure (SOP)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

RESEARCH SERVICE PROVIDER CLINICAL SUPPORT SERVICES HEALTH OUTCOMES SOLUTIONS

1. Introduction, purpose of this Standard Operating Procedure (SOP)

Document Title: Training Records. Document Number: SOP 004

Quality Risk Management ICH Q9

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

OUTSOURCING SURVEY. This year we had 315 industry professionals respond

Regulatory Inspections

International trend on medical device regulatory convergence

managing or activities.

OVERVIEW OF STATEMENT OF MICHAEL MARCHLIK VICE PRESIDENT - QUALITY ASSURANCE AND REGULATORY AFFAIRS MCKESSON TECHNOLOGY SOLUTIONS

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Standard Operating Procedures (SOP) Research and Development Office

12+ Interactive Sessions. 5+ Workshops. 5+ Keynote Lectures. 20+ Exhibitors. 50+ Plenary Lectures. Patient Safety & Quality Healthcare.

Role and Vision of PMDA

Ireland Future R&D Investment in a Small Open Economy Opportunities and Threats. Third KEI Workshop Helsinki

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Effective Date: 11/09 Policy Chronicle:

Governance and Sustainability of EOSC Ambitions, Challenges and Opportunities

First inspection of a Legal Representative in the EU by local authority

Audit and Inspection

MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC

Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland

Transcription:

STEERING COMMITTEE NOMINEES FOR THREE VACANCIES MARCH 2018 KRISTEN BRETZIUS PSI Documentation Center Manager CRO Change Control Board Member Artifact Subtype Team Zone 4 SME Team (Team Lead) Zone 5 SME Team (Team Lead) I have worked in Records Management for 13 years. I began as a Document Coordinator in a construction company at a major pharmaceutical plant, from there into the role of Data Coordinator with a large CRO and eventually ended up in an entry level position here at PSI. In my 10 years at PSI I have helped initiate two etmfs, managed 100 s of master files and undergone numerous audits with little to no findings in my department. Currently I am in charge of TMF operations for the North America, the U.K., Latin America, and Australia while sharing lead responsibilities for Asia with a European colleague. I have been a member of the TMF RM Group since November of 2016 and volunteer whenever I can, currently on the CCB, Subtypes and the Framework for the Destruction of Paper for the DIA RM Community. Page 1 of 5 March 2018

KATHIE CLARK IQVIA Director, Product Management Vendor Steering Committee Member Artifact Subtype Team Exchange Mechanism Team Exchange Mechanism Vendor Team Inspection Readiness Team (Team Lead) Document Dating Conventions Team I ve been working with etmf for about 10 years, and have participated in the TMF Reference Model since Version 1. During that time, I have worked with many sponsor and vendor organizations, ranging from top 10 pharma companies to boutique CROs, to help them implement TMF technology and best practices. I have been a member of the TMF Reference Model Steering Committee for the last two years. My contributions to the community have included: Leading and preparing deliverables for the Metrics, Inspection Readiness, Working Groups Leading the Zone 7 team for TMF Reference Model Version 3 Participating in the Document Dating Convention and TMF Exchange Working Groups I have also shared my research and learnings about topics ranging from GCP Signature Requirements to Health Authority guidance documents with the community in journal articles, conference presentations and white papers. I look forward to new challenges in advancing the state of the art for TMF! Page 2 of 5 March 2018

DAVID IVES Vertex Pharmaceuticals Inc. Head TMF Compliance & Oversight BioPharma Artifact Subtypes Team Annual Survey Team I love TMF; in fact my car has a bumper sticker that reads I d rather be in my TMF! I have been involved in several DIA working groups and truly value the collective knowledge that is brought to bear through the group. I would relish the opportunity to utilize my experience and expertise to be part of the steering committee for such an amazing organization. I currently run the TMF Compliance & Oversight and Clinical Information Management functions at Vertex and I am currently also the GCP Archivist for the company. I am lucky enough to have a great team and together we oversee the management of the TMF from startup to archiving in a multitude of models with a variety of CRO partners. I have tirelessly driven a broader understanding and appreciation of the importance of a TMF across my organization. In addition to practical knowledge of TMF planning, setup, and maintenance due to my GxP archiving background I have a strong understanding of the regulations and guidance regarding properly archiving TMFs and how to successfully implement procedures and best practices to meet those expectations. I would love to bring that experience to help our great organization continue to succeed. Page 3 of 5 March 2018

RUSSELL JOYCE Heath Barrowcliff Consulting Director Consulting UK User Guide / Implementation Guide Team Observational Studies Team (Team Lead) An instigator of the concept of a process-based TMF index whilst working on a TMF project for Takeda in 2007 (later explored by the GCP Records Managers Association), I am an enthusiastic proponent of the value of the TMF Reference Model, which I steadfastly promote as a records management and information governance consultant advising clients on etmf implementations and associated process improvement opportunities. A former Executive Committee Member of the GCP Records Managers Association and now an Executive Committee Member of the Health Sciences Records and Archives Association (HSRAA), I have led working groups (for HSRAA) to draft, among others, an impact assessment of EU Clinical Trial Regulation 536/2014, guidance on the production of certified copies, and (for an HSRAA / DIA working group) criteria for selecting and evaluating etmf technologies. I am also co-chair of the DIA Document and Records Management Community. I am now leading a new Reference Model team for noninterventional studies. I should very much like use my knowledge and experience to work with the Steering Committee to actively contribute to the continuing success and evolution of the TMF Reference Model. Page 4 of 5 March 2018

JACKIE MORRILL LMK Clinical Research Consulting Director of Clinical Operations Vendor User Guide / Implementation Guide Team Zone 1 SME Team I am a Lean Six Sigma Green Belt certified clinical research professional with over a decade of experience in clinical trial coordination and process improvement in the healthcare, biotech, and pharmaceutical industries. For the past 5 years, my dedicated focus has been on all things TMF; first in the Clinical Operations Document Management group at Biogen and for the past 2 years as a TMF Consultant and Director of Clinical Operations at LMK Clinical Research Consulting. I have assisted clients with etmf and earchive vendor selection and implementation, large migration and QC projects, development of robust metrics and training programs, TMF process improvement, inspection readiness preparation for FDA, MHRA, and PDMA inspections, and so much more. In recent years, I ve watched, with great joy, the TMF start to be given the respect and attention it so deserves and feel as though my participation on the steering committee would enable me to continue to push this trend forward! Page 5 of 5 March 2018